CalciMedica Inc. (CALC) vs Lexaria Bioscience Corp. (LEXX)

CalciMedica Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. CalciMedica Inc. and Lexaria Bioscience Corp. are of similar size ($8.9M and $8.8M). Across the 11 metrics below, Lexaria Bioscience Corp. leads on 7 and CalciMedica Inc. on 4.

Valuation

Metric CALC LEXX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 13.74 9.40
P/B 0.84 1.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.12 n/m 0.66
EV/Sales n/m 7.18 9.02
Earnings yield (496.32%) (115.99%) (32.88%)
Free cash flow yield (410.28%) (101.10%) (23.13%)

Profitability

Metric CALC LEXX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (365.70%) (162.60%) (51.96%)
Return on assets (110.10%) (134.20%) (46.06%)
Return on invested capital 0.00% (662.56%) 0.00%

Growth

Metric CALC LEXX Biotechnology median
Revenue growth (TTM) — 9.08% 6.76%
EPS growth (last fiscal year) (61.48%) (40.43%) 29.88%
Revenue growth, 5-year CAGR — 17.53% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CALC LEXX Biotechnology median
Debt to equity 1.67 0.00 0.00
Current ratio 5.58 10.60 4.97
Net debt to EBITDA 0.14 0.17 1.01

Dividend

Metric CALC LEXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CALC LEXX Biotechnology median
Market cap 8.87m 8.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack